Literature DB >> 17180380

Herpes simplex and varicella-zoster virus infections during pregnancy: current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections.

A Sauerbrei1, P Wutzler.   

Abstract

Varicella during pregnancy can be associated with severe illnesses for both the mother and her neonate. Varicella pneumonia must be regarded as a medical emergency, since pregnant women are at risk of life-threatening ventilatory compromise and death. After maternal chickenpox in the first and second trimesters, congenital varicella syndrome may occur in nearly 2% of the cases. The characteristic symptoms consist of skin lesions in dermatomal distribution, neurological defects, eye diseases and skeletal anomalies. If the mother develops varicella rashes between day 4 (5) antepartum and day 2 postpartum, generalized neonatal varicella leading to death in about 20% of the cases has to be expected. Normal zoster has not been shown to be associated with maternal pneumonia, birth defects or problems in the perinatal period. On the basis of the clinical consequences of varicella-zoster virus infections during pregnancy, the present paper summarizes the currently available concepts of prevention, diagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17180380     DOI: 10.1007/s00430-006-0032-z

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  40 in total

Review 1.  Neonatal varicella.

Authors:  A Sauerbrei; P Wutzler
Journal:  J Perinatol       Date:  2001-12       Impact factor: 2.521

Review 2.  Consensus: varicella-zoster infections in pregnancy and the perinatal period.

Authors:  C G Prober; A A Gershon; C Grose; G H McCracken; J D Nelson
Journal:  Pediatr Infect Dis J       Date:  1990-12       Impact factor: 2.129

3.  Varicella vaccine and infection with varicella-zoster virus.

Authors:  Marietta Vázquez; Eugene D Shapiro
Journal:  N Engl J Med       Date:  2005-02-03       Impact factor: 91.245

4.  Fatal neonatal varicella infection.

Authors:  P Holland; D Isaacs; E R Moxon
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

5.  Congenital varicella-zoster virus infection. A rare case of severe brain and ocular malformations without limb or cutaneous involvement in a newborn after maternal subclinical infection.

Authors:  Yousef A Al-Katawee; Yousef A Al-Hasoun; Mohamed N Taha; Khalid Al-Moslem
Journal:  Saudi Med J       Date:  2005-05       Impact factor: 1.484

6.  Seroprevalence of varicella-zoster virus in the German population.

Authors:  P Wutzler; I Färber; S Wagenpfeil; H Bisanz; A Tischer
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

Review 7.  Chickenpox in pregnancy: revisited.

Authors:  Michael Paul Tan; Gideon Koren
Journal:  Reprod Toxicol       Date:  2005-06-23       Impact factor: 3.143

Review 8.  Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.

Authors:  C Grose
Journal:  Mol Biol Med       Date:  1989-10

9.  Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases.

Authors:  G Enders; E Miller; J Cradock-Watson; I Bolley; M Ridehalgh
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

10.  Varicella: a vaccine preventable disease?

Authors:  Barbara Watson
Journal:  J Infect       Date:  2002-05       Impact factor: 6.072

View more
  22 in total

Review 1.  [Skin infections in pregnancy].

Authors:  R R Müllegger; M Glatz
Journal:  Hautarzt       Date:  2010-12       Impact factor: 0.751

2.  Case 1: Vesicular rash in an infant.

Authors:  Dany Weisz; Jason Brophy
Journal:  Paediatr Child Health       Date:  2010-09       Impact factor: 2.253

Review 3.  Eye pathologies in neonates.

Authors:  Nyaish Mansoor; Tihami Mansoor; Mansoor Ahmed
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

Review 4.  Preventing vertical virus infections: the role of serologic screening of pregnant women.

Authors:  Annemarie Berger; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2018-07-03       Impact factor: 3.402

5.  Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.

Authors:  Andreas Sauerbrei; Anna Schäfler; Jörg Hofmann; Michael Schacke; Bernd Gruhn; Peter Wutzler
Journal:  Clin Vaccine Immunol       Date:  2012-06-20

Review 6.  Varicella-zoster virus (chickenpox) infection in pregnancy.

Authors:  Ronald F Lamont; Jack D Sobel; D Carrington; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Edi Vaisbuch; Roberto Romero
Journal:  BJOG       Date:  2011-05-18       Impact factor: 6.531

7.  Herpes zoster in a 6-month-old infant with 13-year follow-up: a retrospective case report.

Authors:  Kristine J Aikenhead; Theodore L Johnson
Journal:  J Chiropr Med       Date:  2011-12

8.  Infection control best practices in clinical research in resource-limited settings.

Authors:  Catherine Godfrey; Jeffrey T Schouten
Journal:  J Acquir Immune Defic Syndr       Date:  2014-01-01       Impact factor: 3.731

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.